Hydrogel degradation promotes angiogenic and regenerative potential of cell spheroids for wound healing
Source abstract
Abstract
Chronic nonhealing wounds are debilitating and diminish one's quality of life, necessitating the development of improved strategies for effective treatment. Biomaterial- and cell-based therapies offer an alternative treatment compared to conventional wound care for regenerating damaged tissues. Cell-based approaches frequently utilize endothelial cells (ECs) to promote vascularization and mesenchymal stromal cells (MSCs) for their potent secretome that promotes host cell recruitment. Spheroids have improved therapeutic potential over monodisperse cells, while degradable scaffolds can influence cellular processes conducive to long-term tissue regeneration. However, the role of biomaterial degradation on the therapeutic potential of heterotypic EC-MSC spheroids for wound healing is largely unknown. We formed poly(ethylene) glycol (PEG) hydrogels with varying ratios of matrix metalloproteinase (MMP)-degradable and non-degradable crosslinkers to develop three distinct constructs – fully degradable, partially degradable, and non-degradable – and interrogate the influence of degradation rate on engineered cell carriers for wound healing. We found that the vulnerability to degradation was critical for cellular proliferation, while inhibition of degradation impaired spheroid metabolic activity. Higher concentrations of degradable crosslinker promoted robust cell spreading, outgrowth, and secretion of proangiogenic cytokines (i.e., VEGF, HGF) that are critical in wound healing. The degree of degradation dictated the unique secretory profile of spheroids. When applied to a clinically relevant full-thickness ex vivo skin model, degradable spheroid-loaded hydrogels restored stratification of the epidermal layer, confirming the efficacy of scaffolds to promote wound healing. These results highlight the importance of matrix remodeling and its essential role in the therapeutic potential of heterotypic spheroids.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Electrospun Nanofibers in Biomedical Applications · Mesenchymal stem cell research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. Update on management of diabetic foot ulcers10.1111/nyas.13569 ↗
2. Impaired wound healing10.1016/j.clindermatol.2006.12.005 ↗
3. Prevalence and incidence of chronic wounds and related complications: a protocol for a systematic review10.1186/s13643-016-0329-y ↗
4. Human wound and its burden: updated 2020 compendium of estimates10.1089/wound.2021.0026 ↗
5. Cellular versus acellular matrix devices in the treatment of diabetic foot ulcers: interim results of a comparative efficacy randomized controlled trial10.1002/term.2884 ↗
6. Stem cell secretome and its effect on cellular mechanisms relevant to wound healing10.1016/j.ymthe.2017.09.023 ↗
7. Vascular network formation by human microvascular endothelial cells in modular fibrin microtissues10.1021/acsbiomaterials.6b00274 ↗
8. The effect of adipose tissue derived MSCs delivered by a chemically defined carrier on full-thickness cutaneous wound healing10.1016/j.biomaterials.2012.12.014 ↗
9. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing10.1371/journal.pone.0001886 ↗
10. Strategies to capitalize on cell spheroid therapeutic potential for tissue repair and disease modeling10.1038/s41536-022-00266-z ↗
11. Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells10.1016/j.biomaterials.2010.12.035 ↗
12. Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes10.1089/ten.tea.2007.0434 ↗
13. Specificity of 3D MSC spheroids microenvironment: impact on MSC behavior and properties10.1007/s12015-020-10006-9 ↗
14. Spatial localization of endothelial cells in heterotypic spheroids influences notch signaling10.1007/s00109-020-01883-1 ↗
15. Tuning the microenvironment to create functionally distinct mesenchymal stromal cell spheroids10.1007/s10439-023-03162-9 ↗
16. Substrate-dependent modulation of 3D spheroid morphology self-assembled in mesenchymal stem cell-endothelial progenitor cell coculture10.1016/j.biomaterials.2014.05.033 ↗
17. Metalloproteinases and wound healing10.1089/wound.2014.0581 ↗
18. Factors affecting wound healing10.1177/0022034509359125 ↗
19. Collagen/hyaluronan based hydrogels releasing sulfated hyaluronan improve dermal wound healing in diabetic mice via reducing inflammatory macrophage activity
20. Engineered cell-degradable poly(2-alkyl-2-oxazoline) hydrogel for epicardial placement of mesenchymal stem cells for myocardial repair10.1016/j.biomaterials.2020.120356 ↗
21. Modifying decellularized aortic valve scaffolds with stromal cell-derived factor-1alpha loaded proteolytically degradable hydrogel for recellularization and remodeling10.1016/j.actbio.2019.02.002 ↗
22. Maleimide cross-linked bioactive PEG hydrogel exhibits improved reaction kinetics and cross-linking for cell encapsulation and in situ delivery10.1002/adma.201103574 ↗
23. Integrin-specific hydrogels modulate transplanted human bone marrow-derived mesenchymal stem cell survival, engraftment, and reparative activities10.1038/s41467-019-14000-9 ↗
24. Encapsulation of primary salivary gland cells in enzymatically degradable poly(ethylene glycol) hydrogels promotes acinar cell characteristics10.1016/j.actbio.2016.12.049 ↗
25. Biomimetic hydrogels with pro-angiogenic properties10.1016/j.biomaterials.2010.01.104 ↗
26. Designing hydrogels for controlled drug delivery10.1038/natrevmats.2016.71 ↗
27. Effects of the proportion of two different cross-linkers on the material and biological properties of enzymatically degradable PEG hydrogels10.1016/j.polymdegradstab.2019.109067 ↗
28. Vasculogenic bio-synthetic hydrogel for enhancement of pancreatic islet engraftment and function in type 1 diabetes10.1016/j.biomaterials.2013.03.012 ↗
29. PEG-maleimide hydrogels for protein and cell delivery in regenerative medicine10.1007/s10439-013-0870-y ↗
30. Isolation and characterization of endothelial progenitor cells from human blood
31. High-throughput formation of mesenchymal stem cell spheroids and entrapment in alginate hydrogels10.1007/978-1-4939-7741-3_11 ↗
32. Restoring vasculogenic potential of endothelial cells from diabetic patients through spheroid formation10.1007/s12195-018-0531-1 ↗
33. PEG-4MAL hydrogels for human organoid generation, culture, and in vivo delivery10.1038/s41596-018-0036-3 ↗
34. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel10.1016/j.biomaterials.2008.03.016 ↗
35. Concise review: mesenchymal stem cell-based drug delivery: the good, the bad, the ugly, and the promise10.1002/sctm.18-0024 ↗
36. Microvascular endothelial cell shape and size in situ10.1006/mvre.1993.1036 ↗
37. Bovine follicular fluid and serum share a unique isoform of matrix metalloproteinase-2 that is degraded by the oviductal fluid10.1095/biolreprod65.6.1726 ↗
38. Synthetic matrices reveal contributions of ecm biophysical and biochemical properties to epithelial morphogenesis10.1083/jcb.201506055 ↗
39. Functional expression of hgf and hgf receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing10.1634/stemcells.22-3-405 ↗
40. A secreted MMP is required for reepithelialization during wound healing10.1091/mbc.e11-09-0745 ↗
41. Self-assembled wound dressings silence MMP-9 and improve diabetic wound healing in vivo10.1002/adma.201503565 ↗
42. The role of matrix metalloproteinases in wound healing10.7547/87507315-92-1-12 ↗
43. Uncovering the secretome of mesenchymal stromal cells exposed to healthy, traumatic, and degenerative intervertebral discs: a proteomic analysis10.1186/s13287-020-02062-2 ↗
44. Hydrolytically-degradable click-crosslinked alginate hydrogels10.1016/j.biomaterials.2018.07.031 ↗
45. Enzymatically-degradable alginate hydrogels promote cell spreading and in vivo tissue infiltration10.1016/j.biomaterials.2019.119294 ↗
46. Enhanced stem cell retention and antioxidative protection with injectable, ROS-degradable PEG hydrogels10.1016/j.biomaterials.2020.120377 ↗
47. Designing degradable hydrogels for orthogonal control of cell microenvironments10.1039/C3CS60040H ↗
48. Hydrolytic hydrogels tune mesenchymal stem cell persistence and immunomodulation for enhanced diabetic cutaneous wound healing10.1016/j.biomaterials.2023.122256 ↗
49. MMP-2 mediates local degradation and remodeling of collagen by annulus fibrosus cells of the intervertebral disc10.1186/ar4224 ↗
50. Neurite outgrowth in fibrin gels is regulated by substrate stiffness10.1089/ten.tea.2011.0030 ↗
51. Biomaterials that promote cell-cell interactions enhance the paracrine function of MSCs10.1016/j.biomaterials.2017.06.019 ↗
52. Macropore design of tissue engineering scaffolds regulates mesenchymal stem cell differentiation fate10.1016/j.biomaterials.2021.120769 ↗
53. The secretome of hydrogel-coembedded endothelial progenitor cells and mesenchymal stem cells instructs macrophage polarization in endotoxemia10.5966/sctm.2014-0111 ↗
54. A nanocomposite hydrogel delivery system for mesenchymal stromal cell secretome10.1186/s13287-020-01712-9 ↗
55. Increased survival and function of mesenchymal stem cell spheroids entrapped in instructive alginate hydrogels10.5966/sctm.2015-0211 ↗
56. Skin structure-function relationships and the wound healing response to intrinsic aging10.1089/wound.2019.1021 ↗
57. High proliferation and delamination during skin epidermal stratification10.1038/s41467-021-23386-4 ↗